The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

The PTT Test measures the time it takes for blood to clot, assessing the functionality of various clotting factors.

The PTT Test is necessary to diagnose bleeding or clotting disorders, monitor anticoagulant therapy, and evaluate overall clotting function.

No special preparation, such as fasting, is required for the PTT Test. However, inform your doctor about any medications you are taking.

A blood sample is taken from a vein in your arm and analyzed in a laboratory to measure the clotting time.

PTT Test results are usually available within a few hours to 24 hours, depending on the laboratory’s workload.

A positive result indicates past infection with the Dengue virus or successful vaccination against Dengue.

No, additional tests, such as Dengue IgM or PCR, may be required to differentiate recent infections from past ones.

No, the Dengue IgG test is not suitable for diagnosing acute Dengue infection. IgG antibodies appear later in the course of infection.

Dengue IgG antibodies can remain detectable in the bloodstream for months to years after infection or vaccination.

A negative result suggests no detectable Dengue IgG antibodies. If symptoms persist or there is a recent exposure, consult a healthcare provider for further evaluation.